Shelf life – Page 23

How to Write CAPA for Poor Stability Trend Review Practices

Effective Approaches for Writing CAPA in Response to Poor Stability Trend Reviews In the pharmaceutical industry, ensuring the integrity and quality of a product throughout its shelf life is critical.…

How to Close Stability OOT CAPA with Effectiveness Evidence

Effectively Addressing OOT and OOS Deviations in Stability Studies In the highly regulated pharmaceutical environment, stability studies are critical for ensuring product efficacy and safety over time. However, Out of…

Stability Data Poolability: When to Combine and When to Separate Batches

Understanding Stability Data Poolability: Combining and Separating Batches In the pharmaceutical industry, determining the best strategy for stability data poolability is essential for effective shelf life management and regulatory compliance.…

Stability OOS in Biologics: Aggregation and Potency Trend Controls

Addressing Stability OOS in Biologics: Controls for Aggregation and Potency Trends In the highly regulated field of pharmaceutical manufacturing, stability failures such as Out of Specification (OOS) or Out of…

How to Use Historical Stability Data for New Product Risk Assessment

Leveraging Historical Stability Data for Effective Risk Assessment in New Products In pharmaceutical manufacturing, the reliability of product quality over its intended shelf life remains paramount for regulatory compliance and…

Why Stability OOT Escalation Rules Must Be Written Before the Study

Developing Protocols for Stability OOT and OOS Issues Before They Arise In the realm of pharmaceutical manufacturing, the integrity and reliability of Stability Studies are imperative to ensure that products…

Stability Trending for Semi-Solid Products: Rheology and Assay Drift

Guide to Stability Trending for Semi-Solid Products: Rheology and Assay Drift Stability trending is a critical component in pharmaceutical manufacturing, particularly for semi-solid products where factors such as rheology and…

Stability OOS Investigation Templates for QA and QC Teams

Templates for Investigating OOT and OOS in Stability Studies Out-of-Trend (OOT) and Out-of-Specification (OOS) results in stability studies present significant challenges for pharmaceutical quality assurance and quality control (QA/QC) teams.…

How to Handle Missing Stability Time Points in Trend Evaluation

Effective Steps to Address Missing Stability Time Points in Trend Evaluations In pharmaceutical manufacturing, stability studies are critical for ensuring product quality throughout its shelf life. However, missing stability time…

How to Define Alert and Action Limits for Stability OOT

Addressing Out-of-Trend and Out-of-Specification Incidents in Stability Studies In the world of pharmaceutical manufacturing, stability studies are crucial for ensuring product quality over time. However, encountering out-of-trend (OOT) and out-of-specification…

Stability Statistical Analysis for Products with Limited Data

Addressing Stability Challenges with Limited Data in Pharmaceutical Manufacturing Stability testing is a cornerstone of pharmaceutical quality assurance, providing crucial insights into the shelf life and efficacy of products. However,…

Stability OOS Due to Unknown Impurity: Identification and Qualification Path

Understanding and Resolving Stability OOS Due to Unknown Impurity Experiencing out-of-specification (OOS) results in stability studies can be challenging and concerning, particularly when it arises from unknown impurities. Such occurrences…